Clinical Trials on Patients With Subjective Tinnitus in Brazil
Total 8 results
-
University of Sao Paulo General HospitalCompleted
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusUnited States, Austria, Germany, Brazil, Mexico
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
AstraZenecaCompletedPatients With DyslipidemiaBrazil
-
Instituto do Cancer do Estado de São PauloUnknownPatients Diagnosed With Advanced Carcinoma of Uterine Cervix tBrazil
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors | Haemophilia A | Haemophilia B | Relatives to/Carers of PatientsBrazil
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania